The relationship between cho/naa and glioma metabolism: Implementation for margin delineation of cerebral gliomas

Acta Neurochirurgica

Volumn 154, Issue 8, 2012, Pages 1361-1370

  Guo, Jun ^a   Yao, Chengjun ^b   Chen, Hong ^a   Zhuang, Dongxiao ^b   Tang, Weijun ^c   Ren, Guang ^c   Wang, Yin ^a   Wu, Jinsong ^b   Huang, Fengping ^b   Zhou, Liangfu ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

1H MRSI; Cho NAA; Glioma boundary; Metabolism; Needle biopsy; Tumour infiltration

Indexed keywords

CD34 ANTIGEN; CHOLINE; EOSIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; ISOCITRATE DEHYDROGENASE 1; KI 67 ANTIGEN; N ACETYLASPARTIC ACID; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL EVALUATION; CRANIOTOMY; DISEASE ASSOCIATION; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTRAOPERATIVE PERIOD; MALE; NEEDLE BIOPSY; NEURONAVIGATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; BIOPSY, NEEDLE; BRAIN NEOPLASMS; CHOLINE; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84865788281     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-012-1418-x     Document Type: Article

References (37)

1. Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J (2010) Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Am J Surg Pathol 34:1199-1204
2. Capper D, Weissert S, Balss J, Habel A, Meyer J, Jager D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A (2010) Characterization of R132H mutationspecific IDH1 antibody binding in brain tumors. Brain Pathol 20:245-254
3. Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599-601
4. Chen J, Huang SL, Li T, Chen XL (2006) In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: Correlation with histopathology and immunohistochemistry. Neuroradiology 48:312-318 (Pubitemid 43733090)
5. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, Jolesz FA, Black PM (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227-1233 (Pubitemid 40328094)
6. Croteau D, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rock JP, Mikkelsen T (2001) Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: Semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49:823-829 (Pubitemid 32927953)
7. De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 34:721-727
8. Dowling C, Bollen AW, Noworolski SM, McDermott MW, Barbaro NM, Day MR, Henry RG, Chang SM, Dillon WP, Nelson SJ, Vigneron DB (2001) Preoperative proton MR spectroscopic imaging of brain tumors: Correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 22:604-612 (Pubitemid 32318684)
9. Farin A, Suzuki SO, Weiker M, Goldman JE, Bruce JN, Canoll P (2006) Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis. Glia 53:799-808
10. Ganslandt O, Stadlbauer A, Fahlbusch R, Kamada K, Buslei R, Blumcke I, Moser E, Nimsky C (2005) Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: Correlation to standard magnetic resonance imaging and tumor cell density. Neurosurgery 56(291-298):291-298
11. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874 (Pubitemid 17085708)
12. Kemp GJ (2000) Non-invasive methods for studying brain energy metabolism: What they show and what it means. Dev Neurosci 22:418-428
13. Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T (2001) In vivo single-voxel proton MR spectroscopy in brain lesions with ringlike enhancement. NMR Biomed 14:339-349 (Pubitemid 32982698)
14. Liu X, Germin BI, Zhong J, Ekholm S (2010) N-Acetyl peak in MR spectra of intracranial metastatic mucinous adenocarcinomas. Magn Reson Imaging 28:1390-1394
15. Matsumura A, Isobe T, Anno I, Takano S, Kawamura H (2005) Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study J Clin Neurosci 12:416-420 (Pubitemid 40745226)
16. McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106:660-666 (Pubitemid 46536464)
17. McKnight TR, von Dem BM, Vigneron DB, Lu Y, Berger MS, McDermott MW, Dillon WP, Graves EE, Pirzkall A, Nelson SJ (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794-802 (Pubitemid 35222399)
18. Miller BL (1991) A review of chemical issues in 1 H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4:47-52
19. Mirbahai L, Wilson M, Shaw CS, McConville C, Malcomson RD, Griffin JL, Kauppinen RA, Peet AC (2011) 1 H magnetic resonance spectroscopy metabolites as biomarkers for cell cycle arrest and cell death in rat glioma cells. Int J Biochem Cell Biol 43:990-1001
20. Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S (2010) p53 abnormality and tumor invasion in patients with malignant astrocytoma. Brain Tumor Pathol 27:95-101
21. Narayana A, Chang J, Thakur S, Huang W, Karimi S, Hou B, Kowalski A, Perera G, Holodny A, Gutin PH (2007) Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 80:347-354 (Pubitemid 47315848)
22. Park I, Bok R, Ozawa T, Phillips JJ, James CD, Vigneron DB, Ronen SM, Nelson SJ (2011) Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13 C MR metabolic imaging. J Magn Reson Imaging 33:1284-1290
23. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ (2004) 3D MRSI for resected high-grade gliomas before RT: Tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 59:126-137 (Pubitemid 38501516)
24. Quinones-Hinojosa A, Sanai N, Smith JS, McDermott MW (2005) Techniques to assess the proliferative potential of brain tumors. J Neurooncol 74:19-30 (Pubitemid 41194526)
25. Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T (2002) Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51:919-920
26. Sabatier J, Gilard V, Malet-Martino M, Ranjeva JP, Terral C, Breil S, Delisle MB, Manelfe C, Tremoulet M, Berry I (1999) Characterization of choline compounds with in vitro 1 H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol 34:230-235 (Pubitemid 29147057)
27. Sankar T, Caramanos Z, Assina R, Villemure JG, Leblanc R, Langleben A, Arnold DL, Preul MC (2008) Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma. J Neurooncol 90:63-76
28. Schluter M, Stieltjes B, Hahn HK, Rexilius J, Konrad-verse O, Peitgen HO (2005) Detection of tumour infiltration in axonal fibre bundles using diffusion tensor imaging. Int J Med Robot 1:80-86
29. Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol 5:153-160 (Pubitemid 36790344)
30. Shimizu H, Kumabe T, Shirane R, Yoshimoto T (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21:659-665 (Pubitemid 30210427)
31. Stadlbauer A, Buchfelder M, Doelken MT, Hammen T, Ganslandt O (2011) Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma. Cen Eur Neurosurg 72:63-69
32. Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O (2004) Improved delineation of brain tumors: An automated method for segmentation based on pathologic changes of 1 H-MRSI metabolites in gliomas. Neuroimage 23:454-461 (Pubitemid 39370597)
33. Stadlbauer A, Nimsky C, Buslei R, Pinker K, Gruber S, Hammen T, Buchfelder M, Ganslandt O (2007) Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: Correlation of metabolic and histological changes at low tumor infiltration-initial results. Invest Radiol 42:218-223 (Pubitemid 46398859)
34. Udani V, Santarelli J, Yung Y, Cheshier S, Andrews A, Kasad Z, Tse V (2005) Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors. Neurol Res 27:801-806 (Pubitemid 41790264)
35. Wang S, Fang J, Zhang T, Wang B, Chen J, Li X, Zhang S, Zhang W (2011) Magnetic resonance imaging targeting of intracranial glioma xenografts by Resovist-labeled endothelial progenitor cells. J Neurooncol 105:67-75
36. Widhalm G, Krssak M, Minchev G, Wohrer A, Traub-Weidinger T, Czech T, Asenbaum S, Marosi C, Knosp E, Hainfellner JA, Prayer D, Wolfsberger S (2011) Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement. J Neurol Neurosurg Psychiatry 82:512-520
37. Yamahara T, Numa Y, Oishi T, Kawaguchi T, Seno T, Asai A, Kawamoto K (2010) Morphological and flow cytometric analysis of cell infiltration in glioblastoma: A comparison of autopsy brain and neuroimaging. Brain Tumor Pathol 27:81-87